← Eichor
Study identifier: NCT06110403 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness

Condition: Copd  ·  Sponsor: University Hospital, Lille

PhasePhase 1/Phase 2
Planned participants35
Who can joinAll sexes, 40 Years to 75 Years
Healthy volunteersNo

About this study

Multicentre, prospective, non-randomised, single-arm, open label, mechanistic study to investigate the mechanism of action of BGF 160 on ventilation pattern complexity and variability

This description comes directly from the study's public registry record.

Talk to the study team

Thierry PEREZ, MD  ·  0320445962  ·  thierry.perez@chu-lille.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de LilleLille, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06110403